Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294616 · ClinicalTrials.gov registry record · NA
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
A NA study of Gastroparesis and Scleroderma, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03294616 is a NA study of Gastroparesis and Scleroderma that has completed, run by Johns Hopkins University. The registered enrollment target is 23 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03294616, a NA study of Gastroparesis and Scleroderma, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
An innovative method of needleless transcutaneous electroacupuncture (TEA) using a newly developed watch-size stimulator is proposed. Weak electrical current will be delivered via skin surface electrodes to acupuncture points related to gastrointestinal functions. The stimulator can be attached to the skin near the acupuncture points and therefore daily activity of the patient does not need to be altered. Two experiments are designed to prove the feasibility of the proposed therapy for gastric complications of Scleroderma .
Conditions Studied
Interventions
- DEVICE transcutaneous electroacupuncture
Study Locations (1)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2019-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294616
The ClinicalTrials.gov registry entry for NCT03294616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (92% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which transcutaneous electroacupuncture is the first listed.
NCT03294616 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03294616 about?
NCT03294616 is a clinical study titled "Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma". An innovative method of needleless transcutaneous electroacupuncture (TEA) using a newly developed watch-size stimulator is proposed. Weak electrical current will be delivered via skin surface electrodes to acupuncture points related to gastrointestinal functions. The stimulator can be attached to t...
What is the current status of trial NCT03294616?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-02-06. Estimated completion is 2019-11-20.
What conditions does trial NCT03294616 study?
This clinical trial studies the following conditions: Gastroparesis, Scleroderma.
What interventions are being tested in trial NCT03294616?
The interventions under investigation include: transcutaneous electroacupuncture (DEVICE).
Who is sponsoring clinical trial NCT03294616?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03294616 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.